CIK 0001308547 · Large accelerated filer
Dolby Laboratories, Inc.
Sign in to watch- Ticker
- DLB
- Exchange
- NYSE
- Industry
- Patent Owners & Lessors
- FY end
- Sep 27
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900199783
- Phone
- 415 558 0200
- Business address
- 1275 MARKET STREET, SAN FRANCISCO, CA, 94103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $995,945
- in 3 filings, $919K under 10b5-1 plans
Net −$995,945. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −13,000 | $95.00 | $1.2M | 50,010 |
| 2021-02-16 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Option exercise · Employee Stock Option (right to buy) | −13,000 | 36,118 | ||
| 2021-02-09 | YEAMAN KEVIN J President and CEO | Option exercise | +29,457 | $37.35 | $1.1M | 67,709 |
| 2021-02-09 | YEAMAN KEVIN J President and CEO | Sale | −29,457 | $91.95 | $2.7M | 38,252 |
| 2021-02-09 | YEAMAN KEVIN J President and CEO | Sale | −5,357 | $91.86 | $492K | 32,895 |
| 2021-02-09 | YEAMAN KEVIN J President and CEO | Option exercise · Employee Stock Option (right to buy) | −29,457 | 220,929 | ||
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −1,436 | $91.68 | $132K | 50,237 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −227 | $92.23 | $21K | 50,010 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Option exercise | +2,882 | $45.50 | $131K | 52,892 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −2,707 | $91.48 | $248K | 50,185 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −175 | $92.23 | $16K | 50,010 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Option exercise | +23,118 | $45.50 | $1.1M | 73,128 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −22,622 | $91.58 | $2.1M | 50,506 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Sale | −496 | $92.23 | $46K | 50,010 |
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Option exercise · Employee Stock Option (right to buy) | −2,882 | 49,118 | ||
| 2021-02-05 | SHERMAN MARK ANDREW EVP, GEN. COUN. & SECRTY | Option exercise · Employee Stock Option (right to buy) | −23,118 | 0 | ||
| 2021-02-03 | Nicholson Ryan VP, Corporate Controller | Sale | −2,237 | $91.01 | $204K | 10,223 |
| 2021-02-02 | TEVANIAN AVADIS Director | Grant or award | +2,661 | 2,661 | ||
| 2021-02-02 | TEVANIAN AVADIS Director | Sale | −1,814 | $90.00 | $163K | 50,561 |
| 2021-02-02 | Sud Anjali Director | Grant or award | +2,661 | 8,873 |
Page 37 of 52 · 1,021 trades